Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martínez-Sánchez MV, Campillo JA, Gomez JM, Pelaez A, García E, Herranz M, Hernández-Olivo M, Martínez-Alfaro E, Alcaraz A, Muñoz Á, Cano A, McKay MR, Muro M, Minguela A. Bernal E, et al. Among authors: gimeno l. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. J Infect Dis. 2021. PMID: 33928374 Free PMC article.
Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance.
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martínez-García J, Martínez-Escribano J, Torroba A, Ferri B, Abellán DJ, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Among authors: gimeno l. Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25. Cancer Immunol Res. 2019. PMID: 31239317
Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation.
López-Álvarez MR, Campillo JA, Legaz I, Blanco-García RM, Salgado-Cecilia G, Bolarín JM, Gimeno L, Gil J, García-Alonso AM, Muro M, Alvarez-López MR, Miras M, Minguela A. López-Álvarez MR, et al. Among authors: gimeno l. Hum Immunol. 2011 Mar;72(3):229-37. doi: 10.1016/j.humimm.2010.12.015. Epub 2011 Jan 4. Hum Immunol. 2011. PMID: 21215286
NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome.
Guillamón CF, Martínez-Sánchez MV, Gimeno L, Mrowiec A, Martínez-García J, Server-Pastor G, Martínez-Escribano J, Torroba A, Ferri B, Abellán D, Campillo JA, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Among authors: gimeno l. Cancer Immunol Res. 2018 Dec;6(12):1537-1547. doi: 10.1158/2326-6066.CIR-18-0022. Epub 2018 Sep 21. Cancer Immunol Res. 2018. PMID: 30242020
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.
Guillamón CF, Gimeno L, Server G, Martínez-Sánchez MV, Escudero JF, López-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martínez-García J, Martínez-Escribano J, Ferri B, López-Álvarez MR, Moreno-Alarcón C, Moya-Quiles MR, Muro M, Minguela A. Guillamón CF, et al. Among authors: gimeno l. Eur Urol Oncol. 2021 Apr;4(2):246-255. doi: 10.1016/j.euo.2019.04.009. Epub 2019 May 14. Eur Urol Oncol. 2021. PMID: 31411976
KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A. Legaz I, et al. Among authors: gimeno l. Transplantation. 2013 Apr 27;95(8):1037-44. doi: 10.1097/TP.0b013e318286486c. Transplantation. 2013. PMID: 23478359
Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.
Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Gimeno L, Muro M, García-Alonso AM, Martínez-Sánchez MV, Bernardo Pisa MV, Soriano-Díaz S, Pascual-Figal DA, Alvarez-López MR, Minguela A. Blanco-García RM, et al. Among authors: gimeno l. Hum Immunol. 2013 Mar;74(3):318-24. doi: 10.1016/j.humimm.2012.12.001. Epub 2012 Dec 14. Hum Immunol. 2013. PMID: 23247208
MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain.
Campillo JA, López-Hernández R, Martínez-Banaclocha H, Bolarín JM, Gimeno L, Mrowiec A, López M, Las Heras B, Minguela A, Moya-Quiles MR, Legáz I, Frías-Iniesta JF, García-Alonso AM, Álvarez-López MR, Martínez-Escribano JA, Muro M. Campillo JA, et al. Among authors: gimeno l. Dis Markers. 2015;2015:831864. doi: 10.1155/2015/831864. Epub 2015 Mar 9. Dis Markers. 2015. PMID: 25838620 Free PMC article.
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.
Martínez-Sánchez MV, Periago A, Legaz I, Gimeno L, Mrowiec A, Montes-Barqueros NR, Campillo JA, Bolarin JM, Bernardo MV, López-Álvarez MR, González C, García-Garay MC, Muro M, Cabañas-Perianes V, Fuster JL, García-Alonso AM, Moraleda JM, Álvarez-Lopez MR, Minguela A. Martínez-Sánchez MV, et al. Among authors: gimeno l. Oncoimmunology. 2015 Oct 29;5(4):e1093721. doi: 10.1080/2162402X.2015.1093721. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141379 Free PMC article.
KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling.
Gimeno L, Serrano-López EM, Campillo JA, Cánovas-Zapata MA, Acuña OS, García-Cózar F, Martínez-Sánchez MV, Martínez-Hernández MD, Soto-Ramírez MF, López-Cubillana P, Martínez-Escribano J, Martínez-García J, Corbalan-García S, Álvarez-López MR, Minguela A. Gimeno L, et al. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. Cancers (Basel). 2020. PMID: 33076479 Free PMC article.
124 results